Phototherapy and photo-oxidation in premature neonates

Michael Kaplan1, Vadim Gold, Cathy Hammerman

  • 1Department of Neonatology, Shaare Zedek Medical Center, Jerusalem, Israel. kaplan@cc.huji.ac.il

Biology of the Neonate
|October 7, 2004
PubMed

Insights

Phototherapy effectively reduces total plasma bilirubin in premature infants. Short-term treatment showed no significant signs of photo-oxidation, ensuring infant safety during jaundice treatment.

Area of Science:

  • Neonatal Medicine
  • Biochemistry
  • Photobiology

Background:

  • Neonatal jaundice is common, often treated with phototherapy.
  • Phototherapy involves exposing infants to light to reduce bilirubin levels.
  • Concerns exist regarding potential photo-oxidative stress during treatment.

Purpose of the Study:

  • To assess the risk of photo-oxidation in premature neonates undergoing phototherapy.
  • To measure specific biomarkers indicative of oxidative damage.

Main Methods:

  • Blood samples collected from premature infants before and after phototherapy (4 and 24 hours).
  • Measured total plasma bilirubin (TPB), carboxyhemoglobin (COHbc), thiobarbituric acid reacting substances (TBARS), and plasma protein carbonyls.
  • Analyzed data for the overall group and by birthweight subgroups (<1.5 kg and >=1.5 kg).

Main Results:

  • Phototherapy significantly reduced TPB levels in premature infants.
  • No significant increases in COHbc, TBARS, or protein carbonyls were observed, indicating no widespread photo-oxidation.
  • A minor increase in COHbc in the smallest infants (<1.5 kg) was noted but not associated with other oxidative markers.

Conclusions:

  • Short-term phototherapy is effective in lowering bilirubin in premature infants.
  • The treatment does not appear to cause significant photo-oxidation.
  • COHbc changes in the smallest infants warrant consideration but do not indicate systemic oxidative damage from phototherapy.
Abstract